Surprisingly, in both SSc, SSc‐ILD, and IPF patients, regardless of whether in peripheral blood or lung tissue, elevated SPA17 expression was observed in disease groups, correlating positively with disease severity. This evidence concerns the gene SPA17 and interstitial lung disease.